| | | | Index Performance | | Index | Sensex | Nifty | | Open | 18,473.43 | 5,328.15 | | High | 18,703.67 | 5,454.70 | | Low | 18,436.99 | 5,328.15 | | Today's Cls | 18,658.25 | 5,441.45 | | Prev Cls | 18,280.24 | 5,327.25 | | Change | 378.01 | 114.20 | | % Change | 2.07 | 2.14 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | GMDC | 1,632.60 | 20.00 | | Jaiprakash Associates | 1,288.30 | 12.93 | | Tata Power | 1,089.65 | 11.43 | | Jindal Steel | 7,414.50 | 10.61 | | Sobha Developers | 983.55 | 10.10 | | Losers | | Asahi India | 111.20 | -3.56 | | Fertilizers & Chemicals | 25.25 | -3.44 | | Spice Tele | 55.40 | -3.32 | | GSK Consumer | 592.35 | -2.87 | | Corporation Bank | 380.50 | -2.76 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,325 | 568 | | Declines | 1,417 | 557 | | Unchanged | 64 | 20 | | Volume(Nos) | 44.94cr | 79.32cr | | | | | | Market Commentary | | | Sensex scales another record high, closes above 18,650 | | The Sensex closed above the 18,650 mark for the first time on strong gains in IT, capital goods, and banking stocks. | | The record-breaking trend continued on the bourses, with the Sensex crossing another milestone of 18,700 in today's trades. | | | | Domestic indices rallied today following the surge in Asian indices, cheered by the gains in Wall Street after the minutes from the US Federal Reserve supported hopes for another interest rate cut to stimulate economic growth in the USA. Taking cues from strong global trend, the Sensex opened with wide upside gap of 193 points and scaled a new peak of 18,704 by noon on sustained buying in information technology, capital goods, and banking stocks. Peace on political front also supported the market to remain buoyant. The Sensex recorded gains for the third straight session and added 378 points to close at 18,658, while the Nifty moved up by 114 points at 5,441. | | | Movers & Shakers | - Lupin gained marginally on completing arrangements to acquire a significant majority stake in Kyowa Pharmaceutical Industry Co (Kyowa), Japan.
- Panacea Biotec closed in the red despite entering into an agreement with Panjab University for drug discovery project to identify lead molecules for psychiatric disorders.
- Sun Pharmaceutical closed with marginal losses despite receiving the US Food and Drug Administration’s (USFDA) final approval to market its generic version of Novartis Trileptal (oxcarbazepine) tablets.
- Shreyas Shipping & Logistics slipped despite signing a Memorandum of Understanding (MoU) for the purchase of fully cellular ship of 1,021 TEU capacity at a cost of Rs50 crore.
| | | |
Surprisingly, the market breadth was negative. Of the 2,806 stocks traded on the Bombay Stock Exchange (BSE) 1,417 stocks declined, 1,325 stocks advanced, and 64 stocks ended unchanged. Out of 12 sectoral indices on the BSE, ten indices ended in positive territory. The BSE CG index ended firm with gains of 4.37% at 16,631, while the BSE IT index rose 3.25% at 5,049 and The BSE Metal index added 2.58% at 14,444. However, the BSE CD index and the BSE FMCG index ended weak.
Action in several index heavyweights lifted the market. L&T led the pack and shot up by 6.60% at Rs3,372. BHEL soared 4.20% at Rs2,331, Hindlaco surged 3.84% at Rs170, Infosys flared up by 3.74% at Rs2,125 and ACC jumped by 3.53% at Rs1,218. Reliance Energy added 3.40% at Rs1,586, Bharti Airtel advanced by 3.04% at Rs1,072, Satyam Computer moved up by 2.91% at Rs484, and Wipro was up 2.83% at Rs503. However, Dr Reddy's Lab slipped 1.47% at Rs633 while, Bajaj Auto at Rs2,621, Ranbaxy at Rs425, Maruti Udyog at Rs1101, ITC at Rs184 and HLL at Rs224 slipped marginally.
IT stocks rallied sharply on expectations of better quarterly numbers. Tech Mahindra shot up by 9.32% at Rs1,441, Mphasis soared 3.70% at Rs301, HCL Tech flared up by 3.42% at Rs330 and I-flex Solutions added 2.94% at Rs1,919.
Over 2.61 crore Reliance Natural Resources shares changed hands on the BSE followed by Reliance Petroleum (2.44 crore shares), Ispat Industries (1.57 crore shares), Tata Teleservices (1.56 crore shares), and IFCI (1.36 crore shares).
Valuewise, Reliance Industries registered a turnover of Rs433 crore on the BSE followed by Reliance Petroleum (Rs417 crore), Reliance Energy (Rs386 crore), Reliance Communication (Rs353 crore) and Reliance Natural Resources (Rs244 crore).
| | | | | | | | European Indices at 16:10 IST on 10-10-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 | 6595.40 | -20.00 | -0.30 | | CAC 40 Index | 5841.42 | -20.51 | -0.35 | | DAX Index | 7993.73 | 13.29 | 0.17 | | | | | | | | Asian Indices at close on 10-10-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17177.89 | 17.99 | 0.10 | | Hang Seng | 28569.33 | 341.29 | 1.21 | | Kospi Index | 2041.12 | 26.99 | 1.34 | | Straits Times | 3814.45 | -51.30 | -1.33 | | Jakarta Composite Index | 2591.48 | 44.88 | 1.76 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
